Tesla

Amazon

Airbnb

Hyatt Hotels

QUALCOMM

Apple

Goldman Sachs

Morgan Stanley

DraftKings

Las Vegas Sands

The Nightview Fund

NightstaRx Ltd. is a U.K. startup company. Gene therapy is the use of a gene to treat disease. The approach could enable treatments for a several rare conditions caused by mutations in a single gene.

NITE actively manages a narrow portfolio of US equity securities. The fund aims for long-term capital appreciation while attempting to beat the S&P 500 over five years.

On Monday, Nightview Capital made its debut on the ETF market with the launch of The Nightview Fund (NITE). The fund is actively managed and carries a net expense ratio of 1.25%.

First Nightview Capital ETF Uses Long-Term Active Strategy

News for The Nightview Fund ETF (NITE)